$CYDY “4 of the 10 Leronlimab pts died during the 14- 90 day study period due to a combination of disease complications & severe constraints on medical equipment” $HGEN 11/12 Severe-Critical #COVID19 pts were discharged in 5 days (median) after Lenzilumab dosing- superior data.
Just think what a drug that downregulates GM-CSF has other MOAs for fighting the cytokine storm and boosts M2 macrophages that fight the virus would do in that cohort of patients.
News 
Market Data 
Discover 
AI
